Cellebrite DI (CLBT) Other financing activities (2021 - 2025)

Cellebrite DI's Other financing activities history runs 5 years deep, the most recent figure standing at $1.3 million for Q4 2025.

• On a quarterly basis, Other financing activities rose 35.32% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $5.0 million, a 48.21% increase from a year earlier, with the FY2024 full-year figure at $17.3 million, down 9.81% from the prior year.
• Other financing activities grew to $1.3 million in Q4 2025 per CLBT's latest filing, from $1.3 million in the prior quarter.
• Across five years, Other financing activities topped out at $3.6 million in Q1 2022 and bottomed at -$3.6 million in Q2 2022.
• The 5-year median for Other financing activities is $810000.0 (2024), against an average of $799055.6.
• Biggest YoY gain for Other financing activities was 116.84% in 2023; the steepest drop was 82.8% in 2023.
• Year by year, Other financing activities stood at $944000.0 in 2021, then tumbled by 30.4% to $657000.0 in 2022, then increased by 7.0% to $703000.0 in 2023, then jumped by 38.55% to $974000.0 in 2024, then surged by 35.32% to $1.3 million in 2025.
• Per Business Quant, the three latest CLBT Other financing activities figures stand at $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.2 million (Q2 2025).